Cargando…

The effect of antidepressant treatment on white matter integrity in Major Depression

INTRODUCTION: White matter abnormalities have been identified in major depressive disorder (MDD). Although several diffusion tensor imaging studies found decreased fractional anisotropy (FA) in MDD, the effect of antidepressants (AD) treatment on white matter integrity has been insufficiently studie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tourjman, S., Potvin, S., Milan, R., Kouassi, E., Luck, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567142/ http://dx.doi.org/10.1192/j.eurpsy.2022.555

Ejemplares similares

PS76. Effect of antidepressant therapy on white matter in patients with first-episode major depressive disorder
por: Lee, Chun-Te, et al.
Publicado: (2016)

Antidepressant Treatment Normalizes White Matter Volume in Patients with Major Depression
por: Zeng, Ling-Li, et al.
Publicado: (2012)

White matter integrity and pro-inflammatory cytokines as predictors of antidepressant response in MDD
por: Breit, S., et al.
Publicado: (2022)

White matter microstructure and local coherence of functional MRI in major depression
por: Breit, S., et al.
Publicado: (2023)

Potential of antithrombin III as a biomarker of antidepressive effect in major depressive disorder
por: Song, R., et al.
Publicado: (2021)

Longitudinal effects of antidepressant treatment on resting state functional connectivity in adolescents with major depressive disorder
por: Lee, K.H., et al.
Publicado: (2022)

Frontal White Matter Anisotropy and Antidepressant Remission in Late-Life Depression
por: Taylor, Warren D., et al.
Publicado: (2008)

Less basal thyrotropin levels predict antidepressant response in patients with major depression
por: Navinés, R., et al.
Publicado: (2022)

Down and High: Reflections Regarding Depression and Cannabis
por: Langlois, Catherine, et al.
Publicado: (2021)

Effectiveness of antidepressants in bipolar depression
por: Potanin, S., et al.
Publicado: (2021)

PS82. Does Serum Amyloid ß-Protein predict the Response to Antidepressant treatment in Major Depression?
por: Inoue, Megumi, et al.
Publicado: (2016)

Telomere length from peripheral blood DNA in major depressive disorder: a case/control comparison and association with antidepressant treatment response
por: Kalinovic, R., et al.
Publicado: (2023)

PS182. Association between BclI C/G (rs41423247), Hippocampal Shape, and White Matter Integrity of the Parahippocampal Cingulum in Major Depressive Disorder
por: Won, Eunsoo, et al.
Publicado: (2016)

PS191. Association between BclI C/G (rs41423247), Hippocampal Shape, and White Matter Integrity of the Parahippocampal Cingulum in Major Depressive Disorder
por: Won, Eunsoo, et al.
Publicado: (2016)

PS188. Predict value of functional topological features for early response to antidepressant treatment in major depressive disorder
por: Hou, Zhenghua, et al.
Publicado: (2016)

Brain Structural Effects of Antidepressant Treatment in Major Depression
por: Dusi, Nicola, et al.
Publicado: (2015)

PS129. Low TNFAIP3 was normalized with antidepressant in patients with major depressive disorder
por: Hung, Yi-Yung
Publicado: (2016)

PS97. Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

PS92. Serum BDNF and GDNF levels before and after the 12-week antidepressant treatments among outpatients with major depressive disorder
por: Lee, Bun-Hee, et al.
Publicado: (2016)

Vasopressin surrogate marker copeptin as a potential novel endocrine biomarker for antidepressant treatment response in major depression: A pilot study
por: Agorastos, A., et al.
Publicado: (2021)

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
por: Lee, Bun-Hee, et al.
Publicado: (2010)

White Matter Microstructure Alterations Associated With Paroxetine Treatment Response in Major Depression
por: Vieira, Rita, et al.
Publicado: (2021)

Pharmacogenetics to Personalize Dosing of Tricyclic Antidepressants in Major Depressive Disorder: A Randomized Clinical Trial (PITA study)
por: Ter Hark, S., et al.
Publicado: (2023)

S159. REDUCED PROCESSING SPEED IN SCHIZOPHRENIA IS MEDIATED BY WHITE MATTER INTEGRITY
por: Cha, Saetbyeol, et al.
Publicado: (2018)

PS172. Cognitive function and white matter hyperintensity in elderly patients with depression
por: Lee, Miji, et al.
Publicado: (2016)

White matter changes following electroconvulsive therapy for depression: a mega-analysis
por: Belge, J.-B., et al.
Publicado: (2022)

Brain grey matter volume alterations associated with antidepressant response in major depressive disorder
por: Liu, Jia, et al.
Publicado: (2017)

Electroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depression
por: Lyden, H, et al.
Publicado: (2014)

Effects of Uric Acid on the Alterations of White Matter Connectivity in Patients with Major Depression
por: Sohn, Hoyoung, et al.
Publicado: (2018)

Effects of Uric Acid on the Alterations of White Matter Connectivity in Patients with Major Depression
por: Sohn, Hoyoung, et al.
Publicado: (2018)

PS180. Relationship between frontal lobe function and antidepressant treatment in bipolar disorder and major depressive disorder: a near-infrared spectroscopy study
por: Tomioka, Hiroi, et al.
Publicado: (2016)

Predicting the effect of antidepressant treatment on relief from anxiety symptoms
por: Spinrad, A., et al.
Publicado: (2022)

T52. N-ACETYL-CYSTEINE ADD-ON TREATMENT LEADS TO AN IMPROVEMENT OF FORNIX WHITE MATTER INTEGRITY IN EARLY PSYCHOSIS
por: Klauser, Paul, et al.
Publicado: (2018)

The galanin system in depression and antidepressant treatment: focus on the locus coeruleus
por: Sartori, Simone B, et al.
Publicado: (2012)

Studying pre-treatment and ketamine-induced changes in white matter microstructure in the context of ketamine’s antidepressant effects
por: Sydnor, Valerie J., et al.
Publicado: (2020)

Early-Stage Psychotherapy Produces Elevated Frontal White Matter Integrity in Adult Major Depressive Disorder
por: Wang, Tao, et al.
Publicado: (2013)

The association between substance P and white matter integrity in medication-naive patients with major depressive disorder
por: Won, Eunsoo, et al.
Publicado: (2017)

Association Between the C4 Binding Protein Level and White Matter Integrity in Major Depressive Disorder
por: Park, Jihoon, et al.
Publicado: (2022)

PT646. Effects of sex hormone treatment on white matter microstructure in patients with gender dysphoria
por: Kranz, GS, et al.
Publicado: (2016)

“Lactose free” depression- Antidepressant with and without lactose registered in Croatia
por: Svetinović, D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sisijb8o3cbgcuncvag8ej4ueb